Skip to main content

Advertisement

Log in

Alleviation of Dimethylnitrosamine-Induced Liver Injury and Fibrosis by Supplementation of Anabasis articulata Extract in Rats

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Anabasis articulata (Forssk) Moq. (Chenopodiaceae) is an herb, grows in Egypt, and used in folk medicine to treat diabetes, fever, and kidney infections. The protective and therapeutic effects of the ethanol extract of A. articulata aerial parts were evaluated against dimethylnitrosamine (DMN)-induced liver fibrosis, compared with the standard drug, silymarin. Hepatic hydroxyproline content, serum transforming growth factor-β1 (TGF-β1), interleukin 10 (IL-10) and fructosamine were measured as liver fibrosis markers. Hepatic malondialdehyde (MDA), nitric oxide (NO), catalase (CAT), glutathione reductase (GR) and glutathione content (GSH) were measured as oxidant/antioxidant markers. Parallel histopathological investigations were also performed. Protective and therapeutic administration of A. articulata (100 mg/kg daily for 4 weeks), markedly prevented DMN-induced loss in body and liver weights. The extract significantly inhibited the elevation of hepatic hydroxyproline, NO and MDA (P < 0.05), as well as serum fructosamine, and TGF-β1 (P < 0.05) induced by DMN while it restored IL-10 to normal level in both protective and therapeutic groups. Furthermore, A. articulata prevented the depletion in CAT, GR, and GSH levels (P ≤ 0.05). In addition, oral administration of A. articulata extract and silymarin to both protective and therapeutic groups reduced the increase in liver function enzyme activities; alanine and aspartate amintransferases, gamma-glutamyl transferase in addition to alkaline phosphatase, and caused significant increase in serum albumin concentration as compared to DMN group. These data corresponded closely with those obtained for the drug silymarin. Histopathological studies confirmed the biochemical data and revealed remarkable improvement in liver architecture. Thus, it could be concluded that, A. articulata extract exhibited in vivo hepatoprotective and therapeutic effects against DMN-induced liver injury and may act as a useful agent in controlling the progression of hepatic fibrosis through reduction of oxidative stress and improving liver function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Mello T, Ceni E, Surrenti C, Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med. 2008;29:17–21.

    Article  PubMed  CAS  Google Scholar 

  2. Saile B, Ramadori G. Inflammation, damage repair, liver fibrosis-role of cytokines and different cell types. Z Gastroenterol. 2007;45:77–86.

    Article  PubMed  CAS  Google Scholar 

  3. Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, et al. Waist circumference, waist: hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol. 1999;150:1316–24.

    Article  PubMed  CAS  Google Scholar 

  4. Misciagna G, De Michele G, Guerra V, Cisternino AM, Di Leo A, Freudenheim JL. Serum fructosamine and colorectal adenomas. Eur J Epidemiol. 2004;19:425–32.

    Article  PubMed  CAS  Google Scholar 

  5. Hattori Y, Kakishita H, Akimoto K, Matsumura M, Kasai K. Glycated serum albumin-induced vascular smooth muscle cell proliferation through activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by protein kinase C. Biochem Biophys Res Commun. 2001;281(4):891–6.

    Article  PubMed  CAS  Google Scholar 

  6. Adrian JE, Poelstra K, Kamps JA. Addressing liver fibrosis with liposomes targeted to hepatic stellate cells. J Liposome Res. 2007;17:205–18.

    Article  PubMed  CAS  Google Scholar 

  7. Peng XD, Dai LL, Huang CQ, He CM, Chen LJ. Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis. World J Gastroenterol. 2009;15:4720–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP-2 mediated mechanism. Hepatology. 2005;41:1074–84.

    Article  PubMed  CAS  Google Scholar 

  9. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001;35:297–306.

    Article  PubMed  CAS  Google Scholar 

  10. Haggerty HG, Holsapple MP. Role of metabolism in dimethylnitrosamine induced immune suppression: a review. Toxicology. 1999;63:1–23.

    Article  Google Scholar 

  11. Magee PN, Barnes J. Carcinogenic nitroso compounds. Adv Cancer Res. 1967;10:163–246.

    Article  PubMed  CAS  Google Scholar 

  12. Suzuki K, Mitsuoka T. N-Nitrosamine formation by intestinal bacteria. IARC Sci Publ. 1984;57:275–81.

    PubMed  CAS  Google Scholar 

  13. Pradeep K, Mohan CV, Gobianand K, Karthikeyan S. Effect of Cassia fistula Linn. leaf extract on diethylnitrosamine induced hepatic injury in rats. Chem Biol Interact. 2007;167(1):12–8.

    Article  PubMed  CAS  Google Scholar 

  14. Muriel P, Rivera-Espinoza Y. Beneficial drugs for liver diseases. J Appl Toxicol. 2008;28:93–103.

    Article  PubMed  CAS  Google Scholar 

  15. Sharmila Banu G, Kumar G, Murugesan AG. Effect of ethanolic leaf extract of Trianthema portulacastrum L. on aflatoxin induced hepatic damage in rats. Ind J Clin Biochem. 2009;24:414–8.

    Article  CAS  Google Scholar 

  16. Levy C, Seeff LD, Lindor KD. Use of herbal supplements for chronic liver disease. Clin Gastroenterol Hepatol. 2004;2:947–56.

    Article  PubMed  CAS  Google Scholar 

  17. Jia JD, Bauer M, Cho JJ, Ruehl M, Milani S, Boigk G, et al. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1. J Hepatol. 2001;35:392–8.

    Article  PubMed  CAS  Google Scholar 

  18. Schuppan D, Porov Y. Hepatic fibrosis: from bench to bedside. J Gastroenterol Hepatol. 2002;17:S300–5.

    Article  PubMed  Google Scholar 

  19. Hammiche V, Maiza K. Traditional medicine in Central Sahara: pharmacopoeia of Tassili N’ajjer. J Ethnopharmacol. 2006;105:358–67.

    Article  PubMed  Google Scholar 

  20. Kambouche N, Merah B, Derdour A, Bellahouel S, Bouayed J, Dicko A, et al. Hypoglycemic and antihyperglycemic effects of Anabasis articulata (Forssk) Moq (Chenopodiaceae), an Algerian medicinal plant. Afr J Biotechnol. 2009;8:5578–83.

    Google Scholar 

  21. Segal R, Goldzweig-Milo I, Zaitschek DV. The sapogenin content of Anabasis articulata. Phytochemistry. 1969;8:521.

    Article  CAS  Google Scholar 

  22. Alam EA. Phytochemical screening on different plant parts of some succulent plants of Egypt. N Y Sci J. 2011;4:15–8.

    Google Scholar 

  23. Kambouche N, Merah B, Derdour A, Bellahouel S, Younos C, Soulimani R. Antihyperglycemic activity of β-sitoglucosid sterol isolated from the plant of Anabasis articulata (Forssk) Moq. Phytothérapie. 2011;9:2–6.

    Article  CAS  Google Scholar 

  24. Yen MH, Weng TC, Liu SY, Chai CY, Lin CC. The Hepatoprotective effect of Bupleurum kaoi, an endemic plant to Taiwan, against dimethylnitrosamine-induced hepatic fibrosis in rats. Biol Pharm Bull. 2005;28:442–8.

    Article  PubMed  CAS  Google Scholar 

  25. Geng J, Peng W, Huang Y, Fan H, Li S. Ginsenoside-Rg1 from Panax notoginseng prevents hepatic fibrosis induced by thioacetamide in rats. Eur J Pharmacol. 2010;634:162–9.

    Article  PubMed  CAS  Google Scholar 

  26. Metwally NS, Mohamed AM, ELSharabasy FS. Chemical constituents of the Egyptian Plant Anabasis articulata (Forssk) Moq and its antidiabetic effects on rats with streptozotocin induceddiabetic hepatopathy. J Appl Pharm Sci. 2012;2:54–65.

    CAS  Google Scholar 

  27. Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem. 1981;112:70–5.

    Article  PubMed  CAS  Google Scholar 

  28. Schleicher ED, Vogt BW. Standardization of serum fructosamine assays. Clin Chem. 1990;36:136–9.

    PubMed  CAS  Google Scholar 

  29. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem. 1995;41:892–6.

    PubMed  CAS  Google Scholar 

  30. Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids. 1994;59:383–8.

    Article  PubMed  CAS  Google Scholar 

  31. Lubinsky S, Bewley GC. Genetics of catalase in Drosophila melanogaster: rates of synthesis and degradation of the enzyme in flies aneuploid and euploid for the structural gene. Genetics. 1979;91:723–42.

    PubMed  CAS  PubMed Central  Google Scholar 

  32. Erden M, Bor NM. Changes of reduced glutathion, glutathion reductase, and glutathione peroxidase after radiation in guinea pigs. Biochem Med. 1984;31:217–27.

    Article  PubMed  CAS  Google Scholar 

  33. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979;582:67–78.

    Article  PubMed  CAS  Google Scholar 

  34. Strader DB, Bacon BR, Lindsay KL, La Brecque DR, Morgan T, Wright EC, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol. 2002;97:2391–7.

    Article  PubMed  Google Scholar 

  35. Bansal M, Ananthanarayanan VS. The role of hydroxyproline in collagen folding: conformational energy calculations on oligopeptides containing proline and hydroxyproline. Biopolymers. 1988;1988(27):299–312.

    Article  Google Scholar 

  36. Kim HK, Yang TH, Cho HY. Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis. World J Gastroenterol. 2009;15:5200–5.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Oh SW, Kim DH, Ha JR, Kim DY. Anti-fibrotic effects of a methylenedioxybenzene compound, CW209292 on dimethylnitrosamine-induced hepatic fibrosis in rats. Biol Pharm Bull. 2009;32:1364–70.

    Article  PubMed  CAS  Google Scholar 

  38. Wang JH, Shin JW, Son JY, Cho JH, Son CG. Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats. J Ethnopharmacol. 2010;127:534–42.

    Article  PubMed  Google Scholar 

  39. Lee HS, Jung KH, Park IS, Kwon SW, Lee DH, Hong SS. Protective effect of morin on dimethylnitrosamine-induced hepatic fibrosis in rats. Dig Dis Sci. 2009;54:782–8.

    Article  PubMed  CAS  Google Scholar 

  40. Liu H, Wei W, Sun WY, Li X. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells. J Ethnopharmacol. 2009;122:502–8.

    Article  PubMed  CAS  Google Scholar 

  41. Kim EY, Kim EK, Lee HS, Sohn Y, Soh Y, Jung HS, Sohn NW. Protective effects of Cuscutae semen against dimethylnitrosamine-induced acute liver injury in Sprague–Dawley rats. Biol Pharm Bull. 2007;30:1427–31.

    Article  PubMed  Google Scholar 

  42. Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin Chim Acta. 2006;366:190–5.

    Article  PubMed  CAS  Google Scholar 

  43. Bauer M, Schuppan D. TGF beta1 in liver fibrosis: time to change paradigms? FEBS Lett. 2001;502:1–3.

    Article  PubMed  CAS  Google Scholar 

  44. Wells RG. The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J Clin Gastroenterol. 2005;39:S158–61.

    Article  PubMed  CAS  Google Scholar 

  45. Tilg H, Kaser A, Moschen AR. How to modulate inflammatory cytokines in liver diseases. Liver Int. 2006;26:1029–39.

    Article  PubMed  CAS  Google Scholar 

  46. Kumar M, Sarin SK. Is cirrhosis of the liver reversible? Indian J Pediatr. 2007;74:393–9.

    Article  PubMed  Google Scholar 

  47. Wilasrusmee C, Kittur S, Shah G, Siddiqui J, Bruch D, Wilasrusmee S, et al. Immunostimulatory effect of Silybum Marianum (milk thistle) extract. Med Sci Monit. 2002;8:439–43.

    Google Scholar 

  48. Farombi EO, Shrotriya S, Surh YJ. Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-κB and AP-1. Life Sci. 2009;84:149–55.

    Article  PubMed  CAS  Google Scholar 

  49. Kim SK, Seo JM, Chae YR, Jung YS, Park JH, Kim YC. Alleviation of dimethylnitrosamine-induced liver injury and fibrosis by betaine supplementation in rats. Chem Biol Interact. 2009;177:204–11.

    Article  PubMed  CAS  Google Scholar 

  50. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 1996;271:C1424–37.

    PubMed  CAS  Google Scholar 

  51. Karafakioglu YS, Aslan R. Taurine prevents nonylphenol-induced oxidative stress in rats. J Anim Vet Adv. 2010;9:37–43.

    Article  CAS  Google Scholar 

  52. Calabrese EJ, Canada AT. Catalase: its role in xenobiotic detoxification. Pharmacol Ther. 1989;44:297–307.

    Article  PubMed  CAS  Google Scholar 

  53. Noctor G, Foyer CH. Ascorbate and glutathione: keeping active oxygen under control. Annu Rev Plant Physiol Plant Mol Biol. 1998;49:249–79.

    Article  PubMed  CAS  Google Scholar 

  54. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489–92.

    PubMed  CAS  Google Scholar 

  55. Blair IA. Endogenous glutathione adducts. Curr Drug Metab. 2006;7:853–72.

    Article  PubMed  CAS  Google Scholar 

  56. Lee KJ, Choi JH, Kim HG, Han EH, Hwang YP, Lee YC, et al. Protective effect of saponins derived from the roots of Platycodon grandiflorum against carbon tetrachloride induced hepatotoxicity in mice. Food Chem Toxicol. 2008;46:1778–85.

    Article  PubMed  CAS  Google Scholar 

  57. Kiruthiga PV, Shafreen RB, Pandian SK, Devi KP. Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes. Basic Clin Pharmacol Toxicol. 2007;100:414–9.

    Article  PubMed  CAS  Google Scholar 

  58. Pradeep K, Mohan CV, Gobianand K, Karthikeyan S. Effect of Cassia fistula Linn. leaf extract on diethylnitrosamine induced hepatic injury in rats. Chem Biol Interact. 2007;167(1):12–8.

    Article  PubMed  CAS  Google Scholar 

  59. Ahmad R, Ahmed S, Khan NU, Hasnaina AU. Operculina turpethum attenuates N-nitrosodimethylamine induced toxic liver injury and clastogenicity in rats. Chem Biol Interact. 2009;181:145–53.

    Article  PubMed  CAS  Google Scholar 

  60. Ohara F, Nii A, Sakiyama Y, Tsuchiya M, Ogawa S. Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses. Dig Dis Sci. 2008;53:2222–32.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hanan F. Aly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohamed, A.M., Abdalla, M.S., Rizk, M.Z. et al. Alleviation of Dimethylnitrosamine-Induced Liver Injury and Fibrosis by Supplementation of Anabasis articulata Extract in Rats. Ind J Clin Biochem 29, 418–429 (2014). https://doi.org/10.1007/s12291-013-0350-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-013-0350-z

Keywords

Navigation